Cargando...
Cellular Immune Response to an Engineered Cell-Based Tumor Vaccine at the Vaccination Site
The engineered expression of the immune co-stimulatory molecules CD80 and CD137L on the surface of a neuroblastoma cell line converts this tumor into a cell-based cancer vaccine. The mechanism by which this vaccine activates the immune system was investigated by capturing and analyzing immune cells...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2007
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1949498/ https://ncbi.nlm.nih.gov/pubmed/17543914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2007.04.004 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|